Novel cytarabine monophosphate prodrugs

Details for Australian Patent Application No. 2003286816 (hide)

Owner Metabasis Therapeutics, Inc.

Inventors Erion, Mark D.; Boyer, Serge H.

Agent Spruson & Ferguson

Pub. Number AU-B-2003286816

PCT Number PCT/US2003/0346

PCT Pub. Number WO2004/041837

Priority 60/423,259 31.10.02 US; 60/423,211 31.10.02 US

Filing date 31 October 2003

Wipo publication date 7 June 2004

Acceptance publication date 19 August 2010

International Classifications

C07H 19/04 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

C07F 9/6574 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): 60/423,259 31.10.02 US; 60/423,211 31.10.02 US

1 July 2004 Application Open to Public Inspection

  Published as AU-B-2003286816

19 August 2010 Application Accepted

  Published as AU-B-2003286816

16 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003286817-METHOD AND SYSTEM FOR MONITORING ELECTRONIC TRANSACTIONS

2003286815-HYDROTHERMAL DEPOSITION OF THIN AND ADHERENT METAL OXIDE COATINGS FOR HIGH TEMPERATURE CORROSION PROTECTION